Table 2.
Comparison between the lymphoma group and healthy controls
| Lymphoma (N = 64) | Social freezing (N = 365) | P | P (adjusted for age)* | |
|---|---|---|---|---|
| Age (years) | 30.32 ± 4.98 | 36.51 ± 3.17 | <0.001 | |
| Age (years)a | 30.5 (28–34) | 37 (35–39) | <0.001b | |
| Body mass index (kg/m2) | 20.54 ± 8.17 | 22.31 ± 4.79 | 0.2 | |
| AMH (ng/mL) | 1.08 ± 0.74 | 2.03 ± 1.93 | <0.001 | |
| AFC (number of follicles) | 9.41 ± 4.77 | 10.29 ± 3.74 | 0.09 | 0.01 |
| LH at start of stimulation (mIU/mL) | 5.69 ± 3.04 | 3.53 ± 2.77 | <0.001 | |
| No. of days of stimulation | 10.03 ± 2.20 | 9.68 ± 1.91 | 0.2 | 0.1 |
| Total gonadotropins used (units) | 3254.89 ± 1426.83 | 3487.72 ± 1719.31 | 0.3 | 0.1 |
| No. of patients receiving HCG trigger (%) | 58 (90.63) | 320 (87.67) | 0.52 | |
| No. of patients receiving dual trigger (%) | 4 (6.25) | 34 (9.31) | 0.44** | |
| No. of patients receiving leuprolide acetate only trigger (%) | 2 (3.12) | 11 (3.02) | 0.99** | |
| Harvested oocytes | 10.81 ± 6.49 | 12.05 ± 7.31 | 0.2 | 0.03 |
| Frozen oocytes | 8.12 ± 5.54 | 9.57 ± 6.39 | 0.08 | 0.01 |
| Patients who started COH in luteal phase (%) | 4 (6.25) | 4 (1.09) | 0.04** | |
| Used OCPs immediately prior to COH (%) | 9 (14.06) | 110 (30.13) | 0.006 |
Values are expressed as mean ± SD unless otherwise specified
*Linear regression; **Fisher’s exact test
aMedian and interquartile range
bMann-Whitney U